Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
        L01DB Anthracyclines and related substances [DG:DG01682]
          L01DB06 Idarubicin [DG:DG00700]
            D01747  Idarubicin hydrochloride (JP18/USP) <JP/US>

USP drug classification [BR:br08302]
  Antineoplastics
    Molecular Target Inhibitors
      Idarubicin [DG:DG00700]
        D01747  Idarubicin hydrochloride (JP18/USP)

Therapeutic category of drugs in Japan [BR:br08301]
  4  Agents affecting cellular function
    42  Antineoplastics
      423  Antibiotics
        4235  Anthracycline antibiotics
          D01747  Idarubicin hydrochloride (JP18/USP)

Drug groups [BR:br08330]
  Antineoplastic
    DG01682  Anthracycline antineoplastic
      DG00700  Idarubicin
        D01747  Idarubicin hydrochloride
    DG01529  Topoisomerase inhibitor
      DG01527  Topoisomerase II inhibitor
        DG00700  Idarubicin
          D01747  Idarubicin hydrochloride

Target-based classification of drugs [BR:br08310]
  Enzymes
    Isomerases (EC5)
      DNA topoisomerase [EC:5.99.1.-]
        TOP2 [HSA:7153 7155] [KO:K03164]
          D01747  Idarubicin hydrochloride (JP18/USP) <JP/US>

Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
  Chemicals
    D01747  Idarubicin hydrochloride
    D01747  Idarubicin hydrochloride for injection

[ BRITE | KEGG2 | KEGG ]